insurancebusinessmag4d
Canada's personal property insurance market to harden next year – Definity CEO
Definity Financial Corporation president and chief executive Rowan Saunders anticipates Canada’s personal property lines ...
The New Era Of AI-Native Development Emerges At GitHub Universe 2024
As enterprises continue to navigate the complexities of AI and software development, GitHub’s latest innovations offer ...
Benzinga.com26d
Nvidia's New Free, Open Source AI Model Reportedly Outperforms OpenAI's GPT-4o, Anthropic's Claude 3.5 Sonnet
The Nemotron-70B model, built on Meta Platforms Inc.’s META Llama 3.1 framework, has surpassed larger models in benchmark tests, scoring 85.0 in Arena Hard, 57.6 in AlpacaEval 2 LC, and 8.98 in ...
Ottumwa Courier9d
Self-described Nazi becomes first person jailed in Australia for performing outlawed salute
A self-described Nazi has become the first person in Australia to be sentenced to prison for performing an outlawed salute ...
Arizona Daily Star15d
Southern Arizona authors write poetry, a children's book about dinosaurs and more
Take this, on choosing a poetic form: “First it wanted to be/a sonnet, then a sestina ... Independently published. 98 pages. $24.95; $19.95 paperback; $6.99 Kindle. From the Petrified Forest ...
NVIDIA Launches Llama-3.1-Nemotron-70B-Instruct, Outperforming GPT-4o And Claude 3.5 Sonnet
It achieved outstanding results in Arena Hard, with a score of 85.0, AlpacaEval 2 LC, scoring 57.6, and GPT-4-Turbo MT-Bench, ...
Firstpost29d
NVIDIA quietly launched its own AI model, said to be more powerful than GPT-4o, Claude 3.5 Sonnet
It achieved scores of 85.0 on Arena Hard, 57.6 on AlpacaEval 2 LC, and 8.98 on GPT-4-Turbo MT-Bench, surpassing competitors such as GPT-4o and Claude 3.5 Sonnet. This achievement is especially notable ...
tech26d
Nvidia’s New Open-Source AI Model Could Reshape the AI Industry!
including OpenAI’s GPT-4o and Anthropic’s Claude 3.5 Sonnet. Llama-3.1-Nemotron-70B-Instruct achieved remarkable scores, such as 85.0 on the Arena Hard benchmark, 57.6 on AlpacaEval 2 LC, and 8.98 on ...
Yahoo Finance11d
Sonnet BioTherapeutics Announces Issuance of U.S. Patent Covering a Variant IL-18 Incorporated into Two Novel Immunotherapeutic Drug Candidates
PRINCETON, NJ, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing ...